Skip to main content
. 2017 Apr 21;20(4):450–463. doi: 10.1007/s11102-017-0805-y

Fig. 8.

Fig. 8

Performance of MCM7 LI, miR-106b~25 expression and Ki67 LI in identifying patients with unfavorable prognosis. a A summary of AUC ROC calculated for progression/recurrence and post-operative residual tumor accompanied by a graphical representation of those values (b, c). d The expression of MCM7 in residual tumors that progressed or remained stable calculated using the two-sided Mann–Whitney test: *p < 0.05